Amylyx Pharmaceuticals, Inc. (AMLX)
16.11
+0.29
(+1.83%)
USD |
NASDAQ |
Apr 07, 13:08
Amylyx Pharmaceuticals SG&A Expense (TTM) : 62.89M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Disc Medicine, Inc. | 65.38M |
| Cytokinetics, Inc. | 284.27M |
| Ionis Pharmaceuticals, Inc. | 393.68M |
| MediciNova, Inc. | 6.159M |
| Scholar Rock Holding Corp. | 176.20M |